Mechanism of the Ni(0)-Catalyzed Vinylcyclopropane−Cyclopentene Rearrangement
摘要:
A combination of physical organic experiments and quantum chemical calculations were used to construct a detailed mechanistic model for the Ni(0)-N-heterocyclic carbene-catalyzed vinylcyclo-propane-cyclopentene rearrangement that involves a mutistep oxidative addition/haptotropic shift/reductive elimination pathway. No evidence for the intermediacy of radicals or zwitterions was found. The roles of substituents on the vinylcyclopropane substrate and variations in the ligands on Ni were evaluated. It is postulated that bulky carbene ligands facilitate formation of the active catalyst species.
Mechanism of the Ni(0)-Catalyzed Vinylcyclopropane−Cyclopentene Rearrangement
摘要:
A combination of physical organic experiments and quantum chemical calculations were used to construct a detailed mechanistic model for the Ni(0)-N-heterocyclic carbene-catalyzed vinylcyclo-propane-cyclopentene rearrangement that involves a mutistep oxidative addition/haptotropic shift/reductive elimination pathway. No evidence for the intermediacy of radicals or zwitterions was found. The roles of substituents on the vinylcyclopropane substrate and variations in the ligands on Ni were evaluated. It is postulated that bulky carbene ligands facilitate formation of the active catalyst species.
Antibacterial compounds of formula (I) are provided:
as well as stereoisomers, pharmaceutically acceptable salts, esters, and prodrugs thereof; pharmaceutical compositions comprising such compounds; methods of treating bacterial infections by the administration of such compounds; and processes for the preparation of such compounds.
[EN] Antibacterial compounds of formula (I) are provided, as well as stereoisomers, pharmaceutically acceptable salts, esters, and prodrugs thereof; pharmaceutical compositions comprising such compounds; methods of treating bacterial infections by the administration of such compounds; and processes for the preparation of such compounds. [FR] L'invention propose des composés antibactériens de formule (I), ainsi que des stéréoisomères, des sels pharmaceutiques acceptables, des esters et des promédicaments de ceux-ci ; des compositions pharmaceutiques comportant de tels composés ; des procédés de traitement d'infections bactériennes par l'administration de tels composés ; et des procédés pour la préparation de tels composés.
Mechanism of the Ni(0)-Catalyzed Vinylcyclopropane−Cyclopentene Rearrangement
作者:Selina C. Wang、Dawn M. Troast、Martin Conda-Sheridan、Gang Zuo、Donna LaGarde、Janis Louie、Dean J. Tantillo
DOI:10.1021/jo901525u
日期:2009.10.16
A combination of physical organic experiments and quantum chemical calculations were used to construct a detailed mechanistic model for the Ni(0)-N-heterocyclic carbene-catalyzed vinylcyclo-propane-cyclopentene rearrangement that involves a mutistep oxidative addition/haptotropic shift/reductive elimination pathway. No evidence for the intermediacy of radicals or zwitterions was found. The roles of substituents on the vinylcyclopropane substrate and variations in the ligands on Ni were evaluated. It is postulated that bulky carbene ligands facilitate formation of the active catalyst species.